Aurobindo Pharma to manufacture and supply long-acting injectable HIV treatment in 133 countries, offering alternative to ...

International companies are increasingly inking licensing deals with Chinese biotechs as concerns regarding drug pricing and ...

Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval ...

Investing.com -- Ericsson (ST: ERICb) on Tuesday reported a net profit of SEK 4.6 billion in the second quarter of 2025, reversing a SEK 11 billion loss in the same period last year. The turnaround ...

The updated MPP-ViiV agreement is an extension of the voluntary license for cabotegravir for HIV PrEP. ViiV Healthcare has been supporting the generic manufacturers with technical know-how to enable ...

Plaintiffs allege that CRISP and its subsidiary willfully infringed on patented technology by launching a copycat product after terminating a long-standing licensing agreement.

After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...

The Inner House of the Court of Session has refused a reclaiming motion against a decision that the licensee of several patents owned by a UK company was liable to pay royalties until the end of the ...

China-based biotech CARsgen Therapeutics (HKEX: 2171) has strengthened its grip on intellectual property in the CAR-T space ...

The VDP Pool from AccessAdvance has successfully attracted a group of licensees/licensors including ByteDance, Kuaishou, NTT ...

How can countries foster pharmaceutical innovation without making life-saving medicines inaccessible? India’s experience offers a compelling answer and in 2025, the country will mark 20 years since it ...

When blockbuster drugs lose intellectual property protections it can wipe out billions of dollars in revenue for companies ...